Atlas Capital Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.16M Sell
6,248
-858
-12% -$159K 0.14% 129
2025
Q1
$1.49M Hold
7,106
0.19% 101
2024
Q4
$1.26M Buy
7,106
+5,700
+405% +$1.01M 0.16% 110
2024
Q3
$278K Sell
1,406
-5,700
-80% -$1.13M 0.04% 322
2024
Q2
$1.22M Buy
7,106
+5,700
+405% +$978K 0.16% 107
2024
Q1
$256K Sell
1,406
-5,700
-80% -$1.04M 0.04% 330
2023
Q4
$1.1M Hold
7,106
0.16% 105
2023
Q3
$1.06M Sell
7,106
-52
-0.7% -$7.75K 0.17% 100
2023
Q2
$964K Sell
7,158
-113
-2% -$15.2K 0.15% 112
2023
Q1
$1.16M Hold
7,271
0.18% 92
2022
Q4
$1.18M Sell
7,271
-13
-0.2% -$2.1K 0.2% 99
2022
Q3
$978K Sell
7,284
-170
-2% -$22.8K 0.18% 104
2022
Q2
$1.14M Buy
7,454
+476
+7% +$72.9K 0.19% 98
2022
Q1
$1.13M Sell
6,978
-28
-0.4% -$4.54K 0.18% 104
2021
Q4
$949K Sell
7,006
-1,473
-17% -$199K 0.14% 123
2021
Q3
$915K Buy
8,479
+1,779
+27% +$192K 0.15% 119
2021
Q2
$755K Buy
6,700
+70
+1% +$7.89K 0.13% 147
2021
Q1
$717K Buy
6,630
+170
+3% +$18.4K 0.14% 146
2020
Q4
$692K Sell
6,460
-803
-11% -$86K 0.15% 138
2020
Q3
$636K Sell
7,263
-197
-3% -$17.3K 0.15% 149
2020
Q2
$732K Buy
7,460
+1,460
+24% +$143K 0.17% 130
2020
Q1
$457K Hold
6,000
0.14% 164
2019
Q4
$531K Hold
6,000
0.13% 188
2019
Q3
$454K Sell
6,000
-229
-4% -$17.3K 0.14% 195
2019
Q2
$453K Hold
6,229
0.15% 181
2019
Q1
$502K Sell
6,229
-3,402
-35% -$274K 0.18% 151
2018
Q4
$888K Sell
9,631
-5,380
-36% -$496K 0.36% 76
2018
Q3
$1.44M Sell
15,011
-2,385
-14% -$229K 0.48% 52
2018
Q2
$1.66M Buy
17,396
+2,237
+15% +$213K 0.59% 37
2018
Q1
$1.43M Buy
+15,159
New +$1.43M 0.44% 56